AYALA PHARMACEUTICALS
Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala’s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The com... pany has two product candidates under development, AL101 and AL02, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, T-cell Acute Lymphoblastic Leukemia, Desmoid Tumors and Multiple Myeloma (in collaboration with Novartis).
AYALA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.ayalapharma.com
Total Employee:
11+
Status:
Active
Contact:
+972-8-373-1541
Email Addresses:
[email protected]
Total Funding:
72 M USD
Technology used in webpage:
Domain Not Resolving Amazon Mobile Non Scaleable Content HSTS Amazon Virginia Region COVID-19 Amazon Route 53 Amazon SSL Akamai Hosted Beaver Builder
Similar Organizations
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Principia Pharmaceutical Corporation
Principia Pharmaceutical Corporation has created a revolutionary new way to design and develop oral small molecule therapies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-07-27 | BioSight | BioSight acquired by Ayala Pharmaceuticals | N/A |
| 2023-01-19 | Advaxis | Advaxis acquired by Ayala Pharmaceuticals | N/A |
Investors List
Sio Capital Management
Sio Capital Management investment in Post-IPO Equity - Ayala Pharmaceuticals
Redmile Group
Redmile Group investment in Post-IPO Equity - Ayala Pharmaceuticals
Harel Insurance and Financial
Harel Insurance and Financial investment in Series B - Ayala Pharmaceuticals
aMoon Fund
aMoon Fund investment in Series B - Ayala Pharmaceuticals
Novartis
Novartis investment in Series B - Ayala Pharmaceuticals
Israel Biotech Fund
Israel Biotech Fund investment in Series B - Ayala Pharmaceuticals
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series B - Ayala Pharmaceuticals
Israel Biotech Fund
Israel Biotech Fund investment in Series A - Ayala Pharmaceuticals
Official Site Inspections
http://www.ayalapharma.com
- Host name: 172.67.172.82
- IP address: 172.67.172.82
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ayala Pharmaceuticals"
Home - Ayala Pharmaceuticals
AL102 and AL101 were acquired in Q1 2024 by Immunome, Inc.See details»
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger ...
Jul 27, 2023 · Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology asset to Ayala’s portfolio with data anticipated in the first half of 2024.See details»
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Oct 19, 2023 · REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology …See details»
Investor Relations - Ayala Pharmaceuticals
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and …See details»
Ayala Pharmaceuticals - Crunchbase Company Profile …
Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients …See details»
Ayala Pharmaceuticals - Overview, News & Similar companies
Ayala Pharmaceuticals contact info: Phone number: +972 83731541 Website: www.ayalapharma.com What does Ayala Pharmaceuticals do? Ayala Pharmaceuticals, Inc., a …See details»
Ayala Pharmaceuticals - Foreign Startup | Startup Nation Finder
Jul 27, 2023 · Ayala Pharmaceuticals is a clinical-stage precision oncology company dedicated to developing and commercializing potential small molecule therapeutics for patients suffering …See details»
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Oct 19, 2023 · REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage onc...See details»
Ayala Pharmaceuticals Announces First Quarter 2023 Financial …
Jan 19, 2023 · REHOVOT, Israel and MONMOUTH JUNCTION, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology …See details»
Ayala Pharmaceuticals Announces Key Business Objectives for 2022
Jan 4, 2022 · TENACITY is an open-label, multicenter, single arm study that is expected to initially enroll up to 26 patients with Notch-activated R/M TNBC whose disease has recurred or …See details»
Ayala Pharmaceuticals - News, Mergers and Acquisitions, …
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering fro... Read More. Usearch …See details»
Annual Reports - Ayala Pharmaceuticals
1007 North Orange Street, 4th Floor, Wilmington, DE 19801. +1-857-444-0553 . 9 Deer Park Drive, Suite K-1 Monmouth Junction, NJ 08852See details»
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger …
Jul 27, 2023 · Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology asset to Ayala’s portfolio with data anticipated in the first half of 2024.See details»
Ayala Pharmaceuticals Reports Full-Year 2021 Financial Results and ...
Mar 28, 2022 · REHOVOT, Israel and WILMINGTON, Del., March 28, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Ayala or the Company) (Nasdaq: AYLA), a …See details»
Ayala Pharmaceuticals, MD Anderson Cancer Center and the …
Mar 8, 2022 · Under the leadership of Dr. Renata Ferrarotto at M.D. Anderson, this study is focused on determining the effects of AL101, a gamma-secretase inhibitor being developed by …See details»
Ayala Pharmaceuticals, Inc. | Insights
Aug 6, 2024 · OS Therapies Incorporated launched the 14th biopharmaceutical company initial public offering in the US in 2024 on 31 July, selling 1.6 million shares at $4 each to gross …See details»
Ayala Pharmaceuticals Reports Financial Results For the Fiscal Year ...
Feb 10, 2023 · REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (f/k/a Advaxis Inc.) (the “Company,” “New Ayala,” …See details»
Ayala Pharmaceuticals Reports Third Quarter 2022 Financial …
Nov 4, 2022 · Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare …See details»
Ayala Pharmaceuticals Reports First Quarter 2022 Financial Results …
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive …See details»
Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results …
May 14, 2021 · Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare …See details»